Clik here to view.
ARIAD Announces Regulatory Approval for Iclusig® (ponatinib) in Japan
CAMBRIDGE, Mass. ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that its partner Otsuka Pharmaceutical Co., Ltd. (Otsuka) has received approval from the Japanese Pharmaceuticals and...
View ArticleClik here to view.
Agilent Technologies and Burning Rock Sign Agreement on Molecular Diagnostics
SANTA CLARA, Calif. & GUANGZHOU, China Agilent Technologies Inc. (NYSE:A) and Burning Rock today announced they have signed an agreement under which Burning Rock will develop cancer diagnostics...
View ArticleClik here to view.
Samsung Bioepis’ Marketing Authorization Application for SB3 Trastuzumab...
INCHEON, Korea Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency (EMA) has accepted for review the company’s Marketing Authorization Application (MAA) for SB3, a...
View ArticleClik here to view.
Xcell Biosciences Announces Two New International Distributors and Multiple...
SAN FRANCISCO Xcell Biosciences, Inc., today announced it has signed agreements with two international distributors and made a number of international sales for its Avatar™ system. Cambridge...
View ArticleClik here to view.
Acelity Announces Expiration of and Final Results for the Exchange Offer with...
SAN ANTONIO Acelity L.P. Inc. (“Acelity”), a global advanced wound care and regenerative medicine company, today announced the final results of the private offer to Eligible Holders (as defined...
View ArticleClik here to view.
カーディナル・ヘルスがアジア事業を拡大
香港 （ビジネスワイヤ） — 総合的なヘルスケアサービス／製品を提供する世界一流企業のカーディナル・ヘルス（NYSE:CAH）は本日、アジア事業拡大の一環として、当社パウダーフリー手袋の製品ラインを香港に投入すると同時に、使い捨てドレープ／ガウンの分野へ一層浸透していくと発表しました。...
View ArticleClik here to view.
Cardinal Health Expands in Asia
HONG KONG Leading global, integrated healthcare services and products company, Cardinal Health (NYSE:CAH), today announced that it will bring its powder-free gloves product line to Hong Kong while...
View ArticleClik here to view.
10x Genomics’ GemCode™ Technology Utilized for de novo Assembly and Phasing...
PLEASANTON, Calif. 10x Genomics, a company focused on improving and broadening the application of genomic information, today announced the use of the GemCodeTM Technology in a new publication in the...
View ArticleClik here to view.
IncellDxの腫瘍免疫療法向け定量的アッセイOncoTect iOに関する新研究が論文に掲載
米カリフォルニア州メンロパーク （ビジネスワイヤ） — 単一細胞を使用した精密医療技術の企業IncellDx, Inc.は本日、国際的な査読医学誌Cancer Immunology, Immunotherapyが、「非酵素的組織分散とフローサイトメトリーを使用した非小細胞肺がん（NSCLC）での腫瘍細胞および免疫細胞におけるPD-L1/PD-1発現の定量」（Quantification of...
View ArticleClik here to view.
Everyone Is Suffering from “Anti-aging” Due to Aging or Other Various...
SEOUL, South Korea Anti-aging is the biggest concern and interest for everyone in the world. TL Plastic Surgery can help them to get their youth back in the most effective solution with professional...
View ArticleClik here to view.
Insider Scoop: The Truth About Jaw Reduction in Korean Plastic Surgery
SEOUL, South Korea With millions of plastic surgery clinics who advertise THEY are the best in Korea, it is close to impossible to find a decent clinic with a “good” doctor who actually cares. This...
View ArticleClik here to view.
IncellDx发表定量免疫肿瘤学检测OncoTect iO的新研究
加州门罗帕克 (美国商业资讯) — 单细胞精准医学公司IncellDx, Inc.今天宣布，国际性同行评议医学杂志《癌症免疫学与免疫治疗》(Cancer Immunology, Immunotherapy)已发表了一篇题为“采用非酶解组织解离和流式细胞计量术对非小细胞肺癌(NSCLC)肿瘤和免疫细胞上PD-L1 和PD-1表达进行定量”的稿件。公司创始人、首席执行官Bruce...
View ArticleClik here to view.
免疫细胞治疗剂‘Immuncell-LC’，延长胶质母细胞瘤的无进展生存时间1.5倍
韩国首尔 (美国商业资讯)–以“以韩国人中最新确诊的胶质母细胞瘤患者为对象，并用标准疗法和基于CIK诱导杀伤细胞的细胞免疫治疗法的第三期随机临床试验(Phase III randomized trial of autologous cytokine-induced killer cell immunotherapy for newly diagnosed glioblastoma in...
View ArticleClik here to view.
Clik here to view.
Kymab and EpimAb Biotherapeutics Announce Multi-Target, Bispecific Antibody...
CAMBRIDGE, United Kingdom & SHANGHAI Kymab, a leading human monoclonal antibody biopharmaceutical company, and EpimAb Biotherapeutics, an emerging biopharmaceutical company specializing in...
View ArticleClik here to view.
海外投資家が注目するがん治療日本独自技術のANK免疫細胞療法に焦点：リンパ球バンク株式会社
東京 （ビジネスワイヤ） – がん免疫治療で先進的な取り組みをしている京都大学発のベンチャー企業、リンパ球バンク株式会社（本社：東京都千代田区、代表取締役：藤井真則）が、海外投資家から注目されています。 このSmart News Release（スマート・ニュース・リリース）にはマルチメディアのコンテンツが含まれています。リリース全文はこちらから：...
View ArticleClik here to view.
Nitto Denko Avecia Inc. Acquires the Businesses of Irvine Pharmaceutical...
MILFORD, Mass. Nitto Denko Avecia Inc. (Avecia), today announced it has entered into a definitive agreement to acquire the assets of Irvine Pharmaceutical Services (Irvine) and Avrio...
View ArticleClik here to view.
康德乐公司在亚洲扩展业务
香港 (美国商业资讯) — 领先的全球性、综合性医疗保健服务及产品公司康德乐公司(NYSE:CAH)今天宣布，它将在香港推出其无粉手套产品系列，同时进一步进军一次性手术巾和手术衣市场，从而继续其在亚洲的扩张步伐。 尽管美国食品药品管理局(FDA)已在3月宣布拟禁用有粉手术手套1，但亚洲有许多用户仍在使用传统的有粉手套，此类手套可引起医疗专业人员的过敏和呼吸系统问题，对患者的危害可能更大。...
View ArticleClik here to view.
NCKU Alumni in Malaysia Run for Charity
TAINAN, Taiwan Secretariat Ackum, the alumni association of NCKU in Malaysia, hosted the ACKU Charity Run 2016, which highlighted the value of ethnicity-friendly, at the University of Malaya (UM) on...
View ArticleClik here to view.
TL Plastic Surgery “SMAS Lifting” Is the Best Choice for Your Drooping and...
SEOUL, South Korea Now reclaiming your youth is no longer a dream, but feasible goal which can be achieved by TL anti-aging lifting Center, performed by Dr. Jung Yeonho. This Smart News Release...
View Article